SKS Growth Partners exists because health-innovation founders keep hitting the same wall: a working product, real clinical promise, and no commercial engine. We built the firm that we needed when we sat in their seat.
Most health-innovation companies do not fail on science. They fail on the commercial clock.
The firm's partners have run commercialization, finance, and R&D inside venture-backed health companies. We have carried the quota, built the data room, and sat in the board meeting where the runway math gets read aloud.
Health innovation only. Devices, diagnostics, digital health, and AI. The buyers, the evidence bar, and the procurement gauntlet are unlike any other market, and general-purpose growth advice does not survive contact with them.
Our deliverable is a working commercial system inside your company: plan, playbooks, systems, evidence, and buyer access. Slides are a byproduct. Revenue and a closed round are the output.
We do the work inside your company. Discovery calls get made, pilots get designed, the CRM gets built. If a week ends without something shipped, that week failed.
We operate inside our clients' companies and their names stay off the internet. References are shared in conversation, with permission, deal by deal.
We take a small number of clients at a time, and only companies we believe can win. If we are not the right partner, we say so in the first conversation.
Engagements are structured so our upside is tied to yours. We win when the round closes and the revenue lands, not when the hours accumulate.
The partners' combined operating record across health-innovation companies they have built, sold for, and financed.
Capital raised across the partners' ventures, including Series A rounds.
Operating in health innovation: start-ups, commercialization, finance, and R&D.
CBO and CFO operating roles held inside venture-backed companies.
Enterprise go-to-market run across hospital executives, health systems, and distributors.